Coming from a family of health care providers, Dr. Juan Bautista balances teaching students, providing community care, and emphasizing health optimization. At his Anti-Aging clinic Dr. Bautista integrates cutting edge regenerative therapies and bridges the gap with traditional medicine to enhance patient outcomes. At his community clinic he provides primary care focusing on preventative medicine and integrating nutrition, exercise, and metabolic health to all patients. Doctor Bautista also serves globally treating venous stasis ulcers, and vascular disease to underserved countries for the past 13 years including trips to Honduras, Belize, Columbia, and Cuba. Dr. Bautista is an ex collegiate athlete and practices medicine in Fresno, California and splits time in Chicago. He’s the proud father of 4 boys who dance Ballet, play college football, and love to play with their friends. You can follow him @doctorbfitmd.
Juan Bautista, MD
Continue exploring related topics.
VIEW ALLDr. Seeds’ Office Hours – Episode 095
1. Sjögren’s, POTS, Mold, Biofilms & Lumbrokinase (0:45)
2. PMDD, Allopregnanolone & Mitochondrial Efficiency (7:28)
3. Retatrutide, Glucagon & Metabolic Flexibility (20:01)
Cellular Optimization for EDS Surgical Support
Dr. Seeds reviews peptide and supplemental considerations for cellular optimization in an EDS patient preparing for orthopedic surgery. (Question Link)
The Phosphatidylcholine Pathway
Dr. Seeds expands on Journal Club Episode 92 to explore the role of phosphatidylcholine in lipid metabolism, methylation, and mitochondrial integrity during aging. He also highlights how estrogen loss may impact this pathway, especially in pre- and post-menopausal women.
Aging-Associated Decline of Phosphatidylcholine Synthesis is a Malleable Trigger of Natural Mitochondrial Aging
Dr. Seeds explores how age-related decline in phosphatidylcholine synthesis may contribute to mitochondrial aging and why that matters in Cellular Medicine. This discussion connects membrane integrity, mitochondrial function, methylation, and metabolic resilience, while highlighting how this pathway may be more modifiable than we once thought.
1. Managing shingles outbreaks in GLP-1 patient through peptides (0:40)
2. Peptide strategies in suspected ALS (15:56)
3. Improving durability in dementia treatment (25:08)